Correlation of Gene-Expression from the 21-Gene Recurrence Score Between Core Biopsy and Surgical Specimen in Patients with Breast Cancer

被引：0
|
作者：
Orozco, Javier I. J. [1 ]
Matsuba, Chikako [1 ]
Marzese, Diego M. [1 ]
Grumley, Janie G. [1 ]
机构：
[1] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页码：S196 / S197
页数：2
相关论文
共 50 条
  • [31] Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
    Woodward, Wendy A.
    Barlow, William E.
    Jagsi, Reshma
    Buchholz, Thomas A.
    Shak, Steven
    Baehner, Frederick
    Whelan, Timothy J.
    Davidson, Nancy E.
    Ingle, James N.
    King, Tari A.
    Ravdin, Peter M.
    Osborne, C. Kent
    Tripathy, Debasish
    Livingston, Robert B.
    Gralow, Julie R.
    Hortobagyi, Gabriel N.
    Hayes, Daniel F.
    Albain, Kathy S.
    JAMA ONCOLOGY, 2020, 6 (04) : 505 - 511
  • [32] Concordance between the 21-gene recurrence score (RS) and the 70-gene profile (MP) in breast cancer (BC) patients (pts)
    Denduluri, N.
    Rugo, H. S.
    Davis, S. E.
    Favret, A.
    Hong, R.
    Au, A.
    Moore, D. H.
    Esserman, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [33] Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?
    Yap, Kelly Khai Li
    Koc, Melissa
    Lu, Janice M.
    Spicer, Darcy V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [35] Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis
    Lu, Yujie
    Tong, Yiwei
    Huang, Jiahui
    Lin, Lin
    Wu, Jiayi
    Fei, Xiaochun
    Chen, Xiaosong
    Shen, Kunwei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6279 - 6289
  • [36] 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes
    Tong, Yiwei
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer.
    King, Tari A.
    Lyman, Jaclyn P.
    Gonen, Mithat
    Voci, Amy
    De Brot, Marina
    Boafa, Camilla
    Sing, Amy Pratt
    Hwang, Eun-Sil Shelley
    Alvarado, Michael
    Liu, Minetta C.
    Boughey, Judy Caroline
    McGuire, Kandace P.
    Van Poznak, Catherine H.
    Jacobs, Lisa K.
    Meszoely, Ingrid M.
    Krontiras, Helen
    Babiera, Gildy
    Norton, Larry
    Morrow, Monica
    Hudis, Clifford
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] The 21-Gene Recurrence Score Influences Treatment Recommendations for Patients With Node-Positive Breast Cancer
    Millien, Jeffanne
    Edwards, Claire
    Kaltman, Rebecca
    McSwain, Anita P.
    McGrail, Lisa
    Teal, Christine B.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 82 - 83
  • [39] Prognostic impact of 21-gene recurrence score in patients with node negative breast cancer in China.
    Zeng, Yinduo
    Qin, Tao
    Li, Qian
    Chen, Kai
    Li, Shunrong
    Jin, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] 21-gene recurrence score® in patients with primary metastatic ER+HER2-breast cancer
    Barinoff, J.
    Anastasiadou, L.
    Brandi, C.
    Junker-Stein, A.
    Silbermann, J.
    Langenfeld, M.
    Fortmann, C.
    Thill, M.
    CANCER RESEARCH, 2017, 77
12345